Welcome to the Sanofi Media Room

Our Media Room is designed to provide reporters with company and product news, as well as key facts, figures and background information.  To help you keep up with the latest news, we offer email alerts and RSS feeds.  If you are a reporter and have questions about the company or our products, visit the Media Contacts page.

Press Releases
Sep 12, 2024
DUPIXENT® (dupilumab injection) approved in Canada for the treatment of children aged 1 year and older with eosinophilic esophagitis (EoE)

This is the ninth indication for DUPIXENT® in Canada and its second in gastroenterology1 Expanded indication marks second disease for which DUPIXENT® is approved in children this young in the...

Jul 26, 2024
Fluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza

The National Advisory Committee on Immunization's (NACI) annual Statement on Seasonal Influenza Vaccines for 2024-2025 continues to recommend Fluzone® High-Dose Quadrivalent among the...

Jul 25, 2024
Ontario Ministry of Health Announces a Universal Public Program with Beyfortus® this RSV Season

The Ontario Ministry of Health has announced a universal public program with Beyfortus® (nirsevimab) for all newborns and infants born in 2024 and through the 2024-2025 RSV season. This also...

More »

Stay Updated
* Required Fields